Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

End the Year Strong With These 3 Comeback Champions

Delta Air Lines, Diamondback Energy, and HEICO could all benefit from internal and external drivers of momentum heading into the end of the year.

Down 45% Year-to-Date, Novo Nordisk Ignites a Price War

Down 45% Year-to-Date, Novo Nordisk Ignites a Price War

Novo Nordisk's new pricing for its GLP-1 drugs is a strategic pivot to capture a mass market, pressure rivals, and secure long-term market dominance.

Institutions Love These 3 Companies, Should You As Well?

Institutions Love These 3 Companies, Should You As Well?

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Data Center Stocks Are Soaring—Analysts Think 1 Could Go Higher

As many data center stocks soar, see where Wall Street analysts are showing trepidation and where they are favoring the potential for upside.

Why GRAIL Stock Could Be Biotech’s Next Big Breakout

Explore insider buying signals, a promising cancer detection biotech, and why the American Dream is still achievable—even in a down market.

Why Ford's Deal With Amazon Is Bigger Than You Think

Ford's Amazon partnership for used cars marks a monumental shift, creating a capital-efficient retail model that leverages its vast dealer network.

Buyer Beware: Carvana Is Driving an Auto Lending Crisis

Carvana has posted enormous gains over the past two years, but its questionable lending practices and underlying financials warrant some concern.

inkl

Read news from The Economist, FT, and more,
with one subscription

Healthcare Rotation Underway: 3 Stocks Leading the Charge

Healthcare Rotation Underway: 3 Stocks Leading the Charge

Are healthcare stocks finally back in fashion? After years of underperformance, a healthcare rotation is underway, led by these three innovative drug makers.

Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum

Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum

Medtronic is on track to advance in 2026 and could rise by 20% to 30% before year-end. Analysts and institutions are accumulating in 2025.

Why Intuitive Machines Is Taking Off While Broader Market Sinks

Why Intuitive Machines Is Taking Off While Broader Market Sinks

Intuitive Machines stock is surging despite a weak market. A new acquisition, bullish analyst sentiment, and insider buying point to long-term growth potential

What’s on the Thanksgiving Table? A Stock Pick for Every Course

What’s on the Thanksgiving Table? A Stock Pick for Every Course

Seaboard, Campbell’s, General Mills, McCormick, and Constellation Brands match every Thanksgiving course—with stocks that could rise this season.

Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain

Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain

Home Depot's Q4 2025 price pullback is a great time to load up on this buy-and-hold stock. The stage is set for a 2026 rebound.

Qualcomm’s Bulls Are Running Out of Room to Be Wrong

Qualcomm’s Bulls Are Running Out of Room to Be Wrong

Qualcomm’s 20% drop means the bulls have given up all their post-earnings gains, and are once again on the backfoot defending a key support line.

Amazon Just Did This—and It Didn't End Well Last Time

Amazon Just Did This—and It Didn't End Well Last Time

Amazon’s RSI crash mirrors last year's setup that preceded a 35% drop. But strong fundamentals would make any dip a major buy this time around.

Get all your
news in one place.

100’s of premium titles.
One news app.

Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything

Merck's multi-billion-dollar acquisition of Cidara Therapeutics is a strategic move to secure a new era of growth with a high-potential antiviral asset.

Stellantis Makes a High-Stakes Bet on Jeep

A product-led revival of the iconic Jeep brand is driving Stellantis's North American recovery, signaling an opportunity for investors.

Nuclear Energy Earnings: Which Names Won and Lost in Q3

Several key nuclear stocks recently reported Q3 earnings. See how markets reacted to the results of NuScale Power, Constellation Energy, and Oklo.

Alphabet: Buffett's Bet on Its Next Phase of Growth

Berkshire's nearly $5 billion position in GOOGL marks a rare Buffett move into high-growth tech, signaling confidence in the company’s next phase of expansion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Why a 20-Second Flight Test Could Unlock Billions for Vertical

Vertical's transition flight is key to its capital-efficient OEM model, a strategy designed for a faster, more profitable path to market leadership.

3 Smart Defensive Stocks for an Uneasy Market

Recession risks persist despite record market highs. Here are three defensive stocks—including PG, JNJ, and the DIA ETF—that can help protect your portfolio

These 3 Stocks Are Using Buybacks to Signal Market Confidence

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

3 Companies to Watch as Natural Gas Stocks Make a Comeback

Natural gas prices are surging. Here are three natural gas stocks that are well-positioned to benefit from rising demand into 2026

Seagate Stock Could Soar as AI Drives Storage Demand

Seagate Technology is on the cusp of a value-building revenue and earnings surge. Analysts and institutional trends point to significant gains in 2026.

Whirlpool’s Worst May Be Over—Upside Opportunity Ahead

Whirlpool's dividend, value, and outlook make it a good buy; the technical situation, institutional, insider, and analysts trends limit the risk.

These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter

The sell-off that began in late October has created numerous buy-the-dip opportunities in the tech, communication services, and consumer discretionary sectors.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

322,979 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play